Cite

HARVARD Citation

    Schieber, T. et al. (2021). Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min. American journal of health-system pharmacy. pp. 2101-2102. [Online]. 
  
Back to record